Author:
Badalato Gina M.,Rutman Matthew P.
Reference28 articles.
1. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64(1):118–40. PubMed PMID: 23541338. Epub 2013/04/02. Eng.
2. Anjum MI, Chari R, Shetty A, Keen M, Palmer JH. Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis. Br J Urol. 1997;80(6):885–8. PubMed PMID: 9439402, Epub 1998/01/24. eng.
3. Fabian KM. The intra-prostatic “partial catheter” (urological spiral) (author’s transl)]. Urologe A. 1980;19(4):236–8. PubMed PMID: 7414771. Epub 1980/07/01. Der Intraprostatische “Partielle Katheter” (Urologische Spirale). ger.
4. Oesterling JE, Kaplan SA, Epstein HB, Defalco AJ, Reddy PK, Chancellor MB. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group. Urology. 1994;44(3):353–62. PubMed PMID: 7521091, Epub 1994/09/01. eng.
5. Juma S, Niku SD, Brodak PP, Joseph AC. Urolume urethral wallstent in the treatment of detrusor sphincter dyssynergia. Paraplegia. 1994;32(9):616–21. PubMed PMID: 7997341. Epub 1994/09/01. eng.